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ABSTRACT 
 
Experimental evidence suggests that epidermal growth factor receptor (EGFR)-mediated 
activation of the signaling protein phospholipase Cγ  plays a critical role in a cancer cell’s 
phenotypic decision to either proliferate or to migrate at a given point in time. Here, we 
present a novel three-dimensional multiscale agent-based model to simulate this cellular 
decision process in the context of a virtual brain tumor. Each tumor cell is equipped with an 
EGFR gene-protein interaction network module that also connects to a simplified cell cycle 
description. The simulation results show that over time proliferative and migratory cell 
populations not only oscillate but also directly impact the spatio-temporal expansion patterns 
of the entire cancer system. The percentage change in the concentration of the sub-cellular 
interaction network’s molecular components fluctuates, and, for the ‘proliferation-to-
migration’ switch we find that the phenotype triggering molecular profile to some degree 
varies as the tumor system grows and the microenvironment changes. We discuss potential 
implications of these findings for experimental and clinical cancer research.   
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1. INTRODUCTION 
 
Malignant brain tumors such as glioblastoma exhibit complex growth patterns. Interestingly, 
experimental observations of such high-grade gliomas suggest that at the same point in time, 
migrating tumor cells do not proliferate and conversely proliferating ones do not migrate. 
While this led Giese et al. (1996) to propose the intriguing concept of “dichotomy” in 
gliomas, the exact molecular mechanism governing this reversible switch has not yet been 
clearly established and, moreover, the impact any such molecular event potentially has  
beyond the scale of a single cancer cell remains to be properly evaluated.  In this situation, in 
silico modeling can help by integrating data and yielding experimentally testable hypotheses. 
In this context, it is noteworthy that the epidermal growth factor (EGF) receptor (EGFR) 
pathway has been shown to be involved at various steps in tumorigenesis, also in gliomas 
(Chicoine and Silbergeld, 1997), and its role for the phenotypic switch has already been 
suggested in the case of breast cancer (Dittmar et al., 2002). As a starting point, in an effort to 
simulate this phenotypic ‘switch’ behavior, we have therefore integrated a cell cycle module 
taken from the literature (Alacon et al., 2004; Tyson and Novak, 2001) into our previously 
developed EGFR gene-protein interaction network model (Athale et al., 2005). In our new 
model now, each cell utilizes the value state of its molecular network to ‘decide’ its 
microscopic phenotype, i.e., migration, proliferation, quiescence, or apoptosis - at every point 
in time. On the micro-macroscopic level, a fixed three-dimensional lattice is employed to 
represent a virtual block of brain tissue, while in the molecular environment, the phenotypic 
behavior of a cell is determined by the dynamical changes in the concentrations of the 
interacting molecular species both inside and around the tumor cell. The result is a closer step 
towards a comprehensive multiscale model of a malignant brain tumor that not only can 
forecast the overall tumor growth dynamics but also monitor the dynamical changes within 
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each cell’s molecular network and the profiles, respectively, that trigger the phenotypic 
switch. In the following section we briefly review relevant works. 
 
 
2. PREVIOUS WORKS 
 
The EGF/EGFR cell signaling system has been studied extensively, both in experimental and 
theoretical works. For instance, Starbuck and Lauffenburger (1992) suggested a mathematical 
model for receptor-mediated cell uptake and processing of EGF. This model simulates the 
mitogenic signal generated by EGF/EGFR binding to the cell surface via stimulation of 
receptor tyrosine kinase activity. In addition, Chen et al. (1996) revealed a possible role for a 
phospholipase C dependent feedback mechanism that attenuates EGF-induced mitogenesis. 
Further, the model of Schoeberl et al. (2002) offered an integrated quantitative dynamic and 
topological representation of intracellular signal networks, based on known components of 
EGF receptor signaling pathways. Lastly, employing a hybrid modeling approach, Sander and 
Deisboeck (2002) argued that both strong heterotype chemotaxis and strong homotype 
chemoattraction, such as through the EGF analogue transforming growth factor alpha (TGF-
α), are required for branch formation within the invasive zone of microscopic brain tumors. 
And indeed, Wang et al. (2005) demonstrated that chemotactic cell migration in response to 
EGF are correlated with invasion, intravasation and metastasis in animal models of breast 
cancer. 
 
More recently, so-called multi-scale modeling platforms that span several biological 
levels of interest drew attention, because of their potential to integrate molecular and 
multicellular experimental data. For instance, in previous works from our laboratory 
(Mansury et al., 2002; Mansury and Deisboeck, 2003; Mansury and Deisboeck, 2004a, b), we 
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concentrated on bridging the macroscopic, microscopic and molecular tumor scales. 
Specifically, Mansury and Deisboeck (2003) proposed a two-dimensional agent-based model 
in which the spatio-temporal expansion of malignant brain tumor cells is guided by 
environment heterogeneities in mechanical confinement, toxic metabolites and nutrient 
sources to gain more insight into the systemic effect of such cellular chemotactic search 
precision modulations. With this model they continued to investigate the relationship between 
rapid growth and extensive tissue infiltration (Mansury and Deisboeck, 2004a). Moreover, by 
calibrating the expression of Tenascin C and PCNA using experimental brain tumor data for 
the migratory phenotype while generating the gene expression for proliferating cells as the 
output, numerical result from this model (Mansury and Deisboeck, 2004b) confirmed that 
among the migratory phenotype the expression of Tenascin C is indeed consistently higher, 
while they reveal the reverse for the proliferating tumor cells, which exhibit consistently 
higher expression of the proliferating cell nuclear antigen (PCNA) gene. Athale et al. (2005) 
extended this agent-based, primarily ‘micro-macro’ framework down to an even more 
enriched sub-cellular level, thus developing a multiscale cancer model that allows monitoring 
the percolation of a molecular perturbation throughout the emergent multi-cellular system. 
Particularly, this model introduced a simplified EGFR pathway as a signal processing module 
that encodes the switch between the cell’s microscopic phenotypes of proliferation and 
migration. The results showed further in silico evidence that behavioral decisions on the 
single cell level impact the spatial dynamics of the entire cancerous system. Furthermore, the 
simulation results yielded intriguing experimentally testable hypotheses such as spatial 
cytosolic polarization of γPLC towards an extrinsic chemotactic gradient (Devreotes and 
Janetopoulos, 2003). While this work already implicitly acknowledged the existence of a cell 
cycle, it however lacked a detailed representation of the cell cycle. Based on the works by 
Tyson & Nowak (2001) who represented eukaryotic molecular mechanisms as sets of 
nonlinear ordinary differential equations and used standard analytical and numerical methods 
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to study their solutions, Alarcon et al. (2004) applied a revised version of their model to the 
case of cancer cells under hypoxic conditions. While Alarcon et al (2004) left hypoxia tension 
constant, in our study here, hypoxia tension is considered a dynamic external condition. 
Therefore, we first modified their cell cycle module to be able to correlate it with the location 
of the cell and then integrated it into our previously developed multiscale agent-based model 
(Athale et al., 2005). The next section details the setup of the model. 
 
 
3. MATHEMATICAL MODEL 
 
Our multi-scale model incorporates both macro-microscopic and molecular environments. In 
the following sections, we will illustrate the characteristics of these environments, proceeding 
in a top-down manner. 
 
3.1. Macro-microscopic environment 
 
We first create a three dimensional rectangular lattice that consists of a grid with 
100100100 ××  points in size representing a block of virtual brain tissue. Each lattice site will 
be assigned a value of αTGF ( 1X ), of glucose ( 14X ), and oxygen tension ( 44k ) representing 
these external chemical cues by normal distribution. To display the effect of chemotaxis, the 
three dimensional lattice is divided into four cubes, depicted in Figure 1.  
 
Figure 1. 
 
The levels of these distributions are weighted by the distance, ijkd , of a given cell from the 
center of cube 4, computed by the previously reported L-infinity metric of measurement 
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(Mansury et al., 2002). The center of cube 4 is assigned the highest glucose and 
αTGF concentrations as well as oxygen tension value, hence rendering it the most “attractive” 
for the chemotactically acting tumor cells. Note that each grid point can be occupied by only 
one cell at each time step. The chemotaxis distributions of αTGF , glucose and oxygen tension 
are described by these underlying equations: 
 
   )/2exp( 221 tijkm
ijk dTX σ−=        (1a) 
)/2exp()( 2214 gijkama
ijk dGGGX σ−−+=      (1b) 
)/2exp()( 2244 oijkama
ijk dkkkk σ−−+=       (1c) 
 
In Eq. 1a, mT stands for the maximum αTGF concentration in the tumor (Moskal et al., 1995), 
tσ  is the parameter that controls the dispersion of the αTGF  level. In Eq. 1b, aG  is the 
minimum blood glucose level while mG  stands for the maximum concentration of glucose in 
blood (Freyer and Sutherland, 1986), with gσ  being the parameter controlling the dispersion 
of glucose. Likewise, in Eq. 1c, ak  is the minimum oxygen tension and mk  represents the 
maximum oxygen tension (Alarcon et al., 2004), oσ  is the parameter controlling the 
dispersion of the oxygen tension level. Note that high oxygen tension equals a low level of 
hypoxia and vice-a-visa.  
 
To begin with, five hundred cancer cells are initialized at the center of the lattice [50,50,50] 
and a replenished nutrient point source, representing a blood vessel, is set in the center of 
cube 4. When the first cancer cell reaches this location, the simulation is terminated. Glucose 
and external αTGF  ( exTGF _α ) concentrations are the two major chemoattractive cues in this 
macro-microscopic environment. Glucose ( 14X ) continues to diffuse throughout the three 
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dimensional lattice with a fixed rate and only the location that harbors the peak concentration 
is replenished at each time step. Furthermore, as a nutrient it is continuously taken up by cells 
to maintain their metabolism. In Eq. 2a, t  represents the time step while ijk  stands for the 
position on the three dimensional lattice and nr  is the cell’s glucose uptake coefficient 
(Mansury et al. 2002). 1D  is the diffusion coefficient of the glucose (Sander and Deisboeck, 
2002).  
 
n
tt rXX −= −11414                                (2a) 
...3,2,1 ,14
2
1
14 =∇=∂
∂ tXD
t
X ijkijk                   (2b) 
 
αTGF , is an autocrine produced hormone which can, in addition, act in a paracrine fashion as 
well as juxtacrine manner (Shvartsman et al., 2001) through triggering, as EGF analogue, the 
EGF-receptor pathway. Thus, cells not only can take up their own αTGF but also that secreted 
by bystander cells. Here, αTGF ( 1X ) degrades and diffuses to its neighborhood at each time 
step. Furthermore, (aside from the cells’ autocrine secretion) its ‘external’ replenishment is 
again restricted only to the site of the virtual blood vessel in cube 4 (compare with Figure 1.). 
It follows that 
 
T
tt SXX += −111                                                                                                     (2c) 
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t
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where 2D is the αTGF diffusion coefficient (Thorne et al., 2004) and TS  is the αTGF secretion 
rate (Forsten and Lauffenburger, 1992). 
Le Zhang et al.: Development of a 3D Multiscale Agent-Based Tumor Model 
 9
Based on the experimentally determined diffusion distance of oxygen in tissue, we have 
limited it to a (rescaled) mµ100  distance from the location of the blood vessel (Carmeliet 
and Jain, 2000). Thus the oxygen diffusion process can be described with the following 
equation: 
 
  ...3,2,1 ,44
244 =∇=∂
∂ tkD
t
k ijk
o
ijk
                                                       (2e) 
 
where oD stands for the diffusion coefficient of oxygen (Carmeliet and Jain, 2000). The 
values of the aforementioned coefficients are listed in Tables 1-4.   
 
Table 1.-4. 
 
3.2. Molecular environment 
 
Turning now to the molecular environment which is comprised of both, an EGFR gene-
protein interaction network and a cell cycle subsystem. The EGFR gene-protein interaction 
network is designed to simulate how the cell processes its phenotype decision with regards to 
proliferation and migration whereas the cell cycle is added to complement the proliferation 
process explicitly.  
       
3.2.1. EGFR gene-protein interaction network 
 
As discussed in detail in Athale et al. (2005), induced by the state of its regulatory EGFR 
gene-protein interaction network (and its microenvironmental cues) a given cell will, at any 
point in time, choose its phenotypic trait such as migration, proliferation or quiescence or turn 
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apoptotic. All molecular species and the coefficients of this network are listed in Tables 1 and 
2, respectively. 
 
Figure 2. 
 
In brief, as displayed in Figure 2 each agent or virtual tumor cell has four layers, i.e., the 
external space, the cell membrane, the cytoplasm and the nucleus. In the external space and  
membrane layers, there are glucose, exTGF _α , sEGFR _ , sEGFRTGF _−α and 
sEGFRppTGF _−α variables. exTGF _α ( 1X ) binds to the receptor sEGFR _ ( 2X ) and 
rapidly dimerizes to sEGFRTGF _2 −α ( 3X ) (Starbuck and Lauffenburger, 1992) which in 
turn is then autophosphorylated to sEGFRppTGF _2 −α ( 4X ). The following equations 
represent these processes: 
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M
M
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Once internalized, the cytoplasmatic EGFRTGF −α  complex ( 5X ) dissociates reversibly to 
cytoplasmic αTGF ( 6X ) and EGFR ( 7X ), denoted by 
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557654433
5 22 XkXXkXkXk
dt
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66812
286876555
6
XkXk
XkXkXXkXk
dt
dX
⋅−⋅+
⋅+⋅−⋅⋅−⋅= −−                  (8)                         
779157976555
7 XkXkXkXXkXk
dt
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There is evidence that increased internalization of 3X and 4X leads to down-regulation of 
EGFR RNA ( 9X ) expression and thus diminished protein content (Hamburger et al., 1991), 
whereas EGFR activation by ligand binding increases αTGF  RNA ( 8X ) synthesis. Both RNA 
species are being transcribed and translated at a constitutive rate (Maruno et al., 1991; Van 
der Valk et al., 1997) and both, protein and RNA are constantly degraded (Mader, 1988), 
 
8141213
8 XkXk
dt
dX ⋅−⋅=                       (10) 
4189161217
9 XkXkXk
dt
dX ⋅+⋅−⋅=                 (11) 
 
with 12X being the pool of nucleotides. The increased phosphorylated EGFRTGF −α  complex 
accelerates the rate of transition from inactive γPLC ( 10X ) to active γPLC ( 11X ). This active 
γPLC exhibits negative feedback inhibition of 4X (Chen et al., 1994, 1996; Wells, 1999) and 
is represented by 
 
41129201121
10 )( XXkkXk
dt
dX ⋅−⋅−⋅=                               (12) 
11214112920
11 )( XkXXkk
dt
dX ⋅−⋅−⋅=                 (13) 
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12171213814916
12 XkXkXkXk
dt
dX ⋅−⋅−⋅+⋅=                (14) 
 
The intracellular glucose concentration ( 13X ) increases through uptake (Noll et al., 2000) 
from the extracellular glucose pool ( 14X ) yet is depleted by both, EGFRTGF −α  
phosphorylation (Eq. 4) (Hertel et al., 1986; Steinbach et al., 2004) and cell metabolism (Eq. 
1), and is described as 
 
132813321423
13 XkXXkXk
dt
dX ⋅−⋅⋅−⋅=                 (15) 
 
3.2.2. Cell cycle 
 
The central element of our simplified module here is the biological ‘on-off’ cell cycle switch 
put forward by Tyson and Novak (2001). Our network also accounts for the effect of hypoxia 
and protein p27 on cell division by incorporating the module previously developed by 
Alarcon et al. (2004). In their cell cycle module, the switching behavior arises from the 
antagonism between cdh1-APC complexes ( 15X ) and cyclin-CDK ( 16X ), with the mass of 
cell ( 17X ) triggering the aforementioned switch. Cell division occurs when 3015 kX <  
and 3116 kX > , where 30k and 31k denote thresholds of cdh1-APC complexes and cyclin-CDK, 
respectively. From Figure 2 we can deduce that protein p27 ( 18X ) is up-regulated under 
hypoxic conditions. Eq. 19 is employed to show this relationship, i.e., if hypoxia is low, the 
cell will have less protein p27, implying a shorter cell cycle. Inversely, if hypoxia is high, 
more protein p27 is generated, resulting in an inhibition of the cell cycle. This inhibitory 
effect of  protein p27 ( 18X ) on the cyclin-CDK ( 16X ) is incorporated in Eq. 17 through an 
additional decay term that is proportional to the concentration of p27. Moreover, Eq. 18 
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describes the value changes of the mass of the cell ( 17X ) during cell cycle which impacts p27 
( 18X ) via Eq. 19. Another feature of Alarcon et al.’s (2004) module is the effect of 
phosphorylated retinoblastoma protein, RB. That is, non-phosphorylated RB (RBNP ( 19X )) is 
known to inhibit CDK ( 16X ) activity (Knudsen et al., 1999) while phosphorylated RB has no 
direct effect (Gardner et al., 2001). To depict this process, RBNP is incorporated into Eq. 16 
as a generic activator for cdh1-APC complexes ( 15X ), which is implicit to inhibit cyclin-CDK 
( 16X ) by Eq. 17. Variables and coefficients of this cell cycle module are listed in Table 3 and 
Table 4. 
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We note that throughout the simulation the cell cycle time ranges between 2.625 ±  hrs and is 
thus in good agreement with data reported in the literature such as in Hegedus et al. (2000). 
 
 
 
3.3.  Cell phenotypes 
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3.3.1. Proliferation and migration 
 
The signaling protein phospholipase γC , γPLC , is known to be involved in directional cell 
movement in response to EGF (Mouneimne et al., 2004) and prognostic relevance of γPLC  
expression in patients with glioblastoma has already been reported by Mawrin et al. (2003). 
For our purposes here particularly noteworthy, Dittmar et al. (2002) demonstrated that 
γPLC is activated transiently in cancer cells, that is to a greater extent during migration and 
more gradually in the proliferating mode. Implementing this concept, we adopt the 
threshold, PLCσ , to decide if the cell should undergo migration or not. Each cell is therefore 
evaluated for its migratory potential ( MP ),  
 
][][ 1111 dt
dXXMP =                          (21)  
 
where 
dt
dX 11 is the change in concentration of γPLC  over time. If MP  is greater than the PLCσ , 
the cell chooses to migrate, otherwise it proliferates or remains quiescent. If the cell decides to 
migrate, it searches for the best location in its vicinity to move to. The candidate ‘best’ 
locations are comprised of all the ‘Von Neumann’ neighborhood sites (Athale et al., 2005) of 
this cell. Eq. 22 (Mansury and Deisboeck, 2003) describes how the cell chooses this most 
attractive location according to: 
jjj LT εψψ )1( −+⋅=                                                                                           (22) 
 
where jT  stands for the perceived attractiveness of location j , jL  represents the correct, non-
erroneous evaluation of location j  that will be defined further below, where ),(~ 2σµε Nj is 
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an error term that is normally distributed with mean µ  and variance 2σ . The parameter ψ  is 
positive between zero and one, 10 ≤≤ψ , and represents the extent of the search precision. 
For example, 1=ψ represents a chemotactic search process operating with a 100 percent 
precision, i.e. tumor cells always evaluate the permissibility of a location without any 
processing error in the receptor network. By contrast, when 0=ψ , tumor cells perform a 
random-walk motion. However, if MP is less than PLCσ  and sEGFRppTGF _−α  is greater 
than EGFRσ  the new cell will occupy one of its Von Neumann neighborhood sites with highest 
jT value (glucose concentration), otherwise it will become quiescent. Based on the results 
presented in Mansury and Deisboeck (2003) we chose here a search precision of 0.7 as this 
had been shown to ensure maximum spatio-temporal expansion of the virtual tumor system.   
 
3.3.2. Quiescence and apoptosis 
 
There are three possibilities that the cell enters the reversible quiescent state: (1) the cell is 
unable to find an unoccupied location to migrate or proliferate into; or (2) the migration 
potential ( MP ) is less than PLCσ  and sEGFRppTGF _−α  is less than EGFRσ ;  and finally, (3) 
the glucose concentration around the cell ranges in between 16 mmol/L and 8 mmol/L. Note 
that if the on site glucose concentration diminishes even further, i.e. below 8 mmol/L, the cell 
turns apoptotic (Freyer and Sutherland, 1986). 
 
 
 
4. RESULTS 
 
Our code here is implemented in Java (Sun Microsystems, Inc., USA) and employs an agent-
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based modeling toolkit (http://cs.gmu.edu/~eclab/projects/mason/) that is combined with in-
house developed classes for representing molecules, reactions and multi-receptors as a set of 
hierarchical objects. Running the simulation 10 times with different random normal 
distribution, gσ , of glucose (Eq. 1b), the algorithm requires a total of 25 h 46 min of CPU 
time on a computer with an IBM Bladecenter machine (dual-processor 32-bit Xeons ranging 
from 2.8-3.2GHz w/2.5GB RAM) and Gigabit Ethernet. Each node runs Linux with a 2.6 
kernel and Sun's J2EE version 1.5. 
 
Volumetric growth dynamics: We measure the tumor system’s [total] volume by counting 
the number of the lattice sites occupied by a tumor cell regardless of its phenotype, hence 
lumping together both proliferative and migratory driven expansion. Figure 3 shows the 
increase in tumor system volume over time for the 10 simulation runs. The volume increase is 
not smooth, rather shows “jumps” or steps at distinct time points with a marked acceleration 
of the growth rate at later stages.  
                                                     
Figure 3. 
 
Macroscopic behavior: Based on several of these stepping points reported in Figure 3, we 
display in Figures 4.(a)-(c) the three-dimensional snapshots of the tumor at time points t = 50, 
88 and 107. Note that blue color represents proliferating cells, red represents migrating, green 
represents quiescent and grey represents dead tumor cells; one ‘time step’ is equal to 2.5 
hours. 
  
Figure 4. (a)-(c) 
 
Le Zhang et al.: Development of a 3D Multiscale Agent-Based Tumor Model 
 17
While at an early stage (Figure 4(a)) the proliferate tumor core appears to be completely 
surrounded by a cloud of migratory cells, at a later time point, a more heterogeneous picture 
emerges (Figure 4(b)). Ultimately, a tip-population of migratory cells can be found adjacent 
to the location of the source in cube 4 (Figure 4(c); compare also with Figure 1).  
 
Phenotypic behavior: Not surprisingly, due to the comparably low molecular values of the 
cells’ triggering network, at early time points overall tumor growth is largely dominated by 
the proliferative phenotype (Figure 5). However, when molecular values increase sufficiently, 
more cells switch (after 41=t ) to the migratory trait. While the gains in the proliferative cell 
population overall appear to correspond well to the increases seen in the tumor system’s 
volume curve (Figure 3, above), the oscillatory behavior in these phenotypic sub-population 
dynamics suggests that after 52=t , an intermediate, migration-dominant expansion phase 
triggers a second proliferation-dominant growth phase after t = 81.  
 
Figure 5. 
 
Molecular phenotype-switching profiles: We have also investigated the percentage change 
in the components of the EGFR network1 and thus the molecular profile that leads to the 
phenotypic switch. We focused on time points, 52=t and 81, where the population curves 
cross or nearly cross, i.e., 116=t  (compare with Figure 5 (above)). While it is evident from 
the ‘migration-to-proliferation’ switch that the qualifying molecular profile remains very 
similar over time (Figures 6.(d) and 6.(e)) the situation becomes less stationary in the 
‘proliferation-to-migration’ events (Figures 6(a)-(c)). For instance, while a percentage 
increase in γPLC  active phosphorylated Ca-bound ( 11X ) seems to remain a requirement for 
                                                 
1 Note: cell cycle components are not listed as they are currently only activated once a cell decides to proceed to 
proliferation. 
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the switch towards migration throughout, γPLC inactive Ca-bound ( 10X ) appears to start 
playing a more significant role at later stages of tumor expansion ( 116=t ).  
 
Figure 6.(a)-(e) 
 
 
5. DISCUSSION & CONCLUSIONS 
 
For a variety of cancers, the epidermal growth factor receptor, EGFR, has been shown to be 
critically involved in directional motility, or chemotaxis, both in vitro and in vivo (Bailly et 
al., 2000; Soon et al., 2005; Wyckoff et al., 2000). However, there have been conflicting 
reports in the literature regarding the prognostic significance of EGFR gene amplification and 
over-expression in patients with high-grade gliomas, particularly glioblastomas (for a recent 
review, see e.g. Quan et al., 2005). It then becomes apparent that crucial biological 
information is being lost by focusing on the gene level only, without consideration of EGFR’s 
extensive protein downstream signaling cascade and its influence on the cell’s phenotypic 
behavior, respectively. Ideally, one would want to investigate the dynamics of the subcellular 
gene-protein interaction network without losing sight of the multicellular patterns and 
ultimately clinical prognosis any such molecular events may lead to. While it is difficult if not 
impossible, at least for the moment, to realize this in a single experimental setup, integrative 
computational modeling is advancing towards a level that can provide valuable insights. Here, 
we present such a novel 3D multi-scale agent-based model that encompasses the macroscopic, 
microscopic and molecular scale of a virtual brain tumor. Each in silico cell is equipped with 
an EGFR gene-protein interaction module that connects to a simplified cell cycle description. 
A tumor cell’s phenotypic decision to either proliferate or migrate (or to become quiescent) is 
determined by the dynamic change in the values of the sub-cellular network’s molecular 
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components. These concentration values are impacted by cell-cell signaling, such as through 
αTGF , and by environmental cues, including nutrients such as glucose, and hypoxia. 
  
The results show that over time proliferative and migratory cell populations not only oscillate, 
thus suggesting a dynamic relationship, rather, this microscopic behavior directly impacts also 
the spatio-temporal expansion of the entire cancer system. That is, the secondary increase in 
the proliferative cell population seen after time step 81 (Figure 5) is paralleled by a 
substantial acceleration of the spatio-temporal expansion of the entire tumor system (Figure 
3). Most intriguingly, however, the percentage change in the concentration of the network’s 
molecular components varies, in some instances considerably. A specific example is inactive 
Ca-bound γPLC  ( 10X ), a network component that appears to start playing a more significant 
role for the transition to a migratory phenotype at later stages of tumor expansion (Figure 6c). 
In fact, the behavior of the two phenotypic cell populations over time warrants a more 
detailed inspection: while the first ‘crossover’ (Figure 5), i.e., the increase in the migratory 
cell population over the proliferative population at time step 52, can be easily explained by 
the gradual increase of active γPLC  ( 11X ), yielding a higher migratory potential according to 
Eq. 21, the second crossover at time step 81 is unexpected since the concentration of active 
γPLC  ( 11X ) continues to build up. One can argue that this is an emergent property of the 
system since no a priori condition in the algorithm force such behavior. Afterwards, the 
migratory cell fraction rapidly re-approaches the proliferative population in time step 116. We 
note here that since many new cells are generated around time step 107 and since (in this first 
iteration) a genetically stabile progeny inherits the molecular values of the parental cells, 
these daughter cells are equipped with an already high concentration of active λPLC ( 11X ) 
that predisposes them (through Eq. 21) to a rapid transition towards the migratory phenotype, 
much like we saw in the earlier steps of tumor growth. 
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Aside from its technical merits, admittedly, our modeling approach relies on several 
simplifications on the biology side and thus inevitably harbors a number of drawbacks. For 
instance, currently, (apart from the cell-cycle module) the underlying EGFR network itself 
operates with only two genes, EGFR and αTGF , and as such a variety of related signaling 
pathways, such as the mitogen activated protein kinase (MAPK) cascade (Schoeberl et al., 
2002) and others, deserve proper consideration in future iterations of the model. Also, for the 
moment, the algorithm is focused on a set of epigenetic changes and does not yet take 
heterogeneity inducing genetic instability, a hallmark of cancer progression, into account. As 
such, the current setting does not yet allow for dynamic alterations of EGFR gene and protein 
during tumorigenesis, such as through amplification and over-expression as reported widely 
for high grade gliomas (e.g., Ekstrand et al., 1991). Efforts are, however, underway in our 
group to address some of these shortcoming in future works.  
 
Nonetheless, our results already confirm the impact post-translational regulation can 
have on tumor cell behavior, both on the single cell and multicellular level. Furthermore, 
indicating that over time, differing molecular network states may be able to trigger similar 
phenotypic behavior, our findings question the value of single time point gene-expression 
assessments for clinical predictions, thus corroborating recent reports from Rich et al. (2005) 
and Ouan et al. (2005) that find no prognostic value in EGFR gene amplification. Rather, our 
results postulate dynamic monitoring of a tumor’s gene-protein interaction level with 
techniques such as phospho-proteomics (Blagoev et al., 2003) that already have demonstrated 
their value as outcome predictors for patients with brain tumors (Schwartz et al., 2005). 
Absent any clinically available non-invasive molecular imaging, monitoring of the spatio-
temporal dynamics in gene-protein interaction levels would have to be achieved with 
specimen from consecutive biopsies, in parallel to assessing the tumor system’s overall 
expansion through MR imaging time series. Intriguingly, a recent clinical study on such 
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‘image-guided proteomics’ seems to support our findings at least in part as these authors 
report distinctively different protein expression profiles in the glioblastomas’ contrast-
enhanced rim zone (which is arguably where the ‘proliferation-to-migration’ (Figure 6 (a)–
(c)) transition occurs) despite similar histological findings (Hobbs et al., 2003). 
 
In conclusion, this novel three-dimensional computational model is an important step in 
simulating tumor growth dynamics over multiple scales of interest. While extensions will be 
necessary to account in greater detail for the complexity of the biology involved, we believe 
that if properly combined with experimental data, advanced in silico platforms such as this 
one will evolve into powerful integrative research platforms that improve our understanding 
of tumorigenesis.   
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CAPTIONS 
 
Figure 1: Shown is the underlying 3D lattice, with cube 4 harboring the nutrient source (see 
text for details).  
 
Figure 2: The diagram displays the sub-cellular EGFR gene-protein interaction network that 
combines nucleus, cytoplasm and membrane compartments.  
 
Figure 3: Depicted is the tumor system volume (y-axis) over time (x-axis). Shown are mean 
values of 10 simulation runs with random standard deviation of the glucose concentration at a 
range between 50 and 60 mmol/l.  
 
Figure 4: Shown are 3D snapshots of the tumor system at time step t = 50 (a), t =88 (b), t = 
107 (c). 
 
Figure 5: Shown are population dynamics (y-axis) of the proliferative (closed circles) and 
migratory cell populations (open circles) over time (x-axis). 
 
Figure 6: Depicted are the average molecular “proliferation-to-migration” profiles (of n cells) 
at time step (a) t = 52 (n = 3), (b) t = 81 (n = 43), and (c) t = 116 (n = 161), as well as the 
average “migration-to-proliferation” profiles at time step  (d) t = 81 (n = 485), and (e) t = 116 
(n = 114). The x-axis denotes the network components (from 1X  to 14X ; compare with Fig. 
2), while the y-axis represents the percentage change [%] of these molecular species.   
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Table 1: Symbols of the EGFR gene-protein interaction network taken from the literature 
(Athale et al., 2004; Thorne et al., 2004; Sander et al., 2002)∗. 
 
Table 2: Coefficients of the EGFR gene-protein interaction network taken from the literature 
(Athale et al., 2004; Thorne et al., 2004; Sander et al., 2002). 
  
Table 3: Symbols of the cell cycle module taken from the literature (Tyson and Novak 2001; 
Alarcon et al., 2004). 
 
Table 4: Coefficients of the cell cycle module taken from the literature (Tyson and Novak 
2001; Alarcon et al., 2004). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
∗ Note (for Tables 1-4): Reasonable estimates were used where no published values were 
available. 
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FIGURE 4.(a) 
 
FIGURE 4.(b) 
 
FIGURE 4.(c) 
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FIGURE 6.(a) 
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 FIGURE 6.(d) 
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Table 1.  
 
Symbol Variable Initial Value [ nM ] 
1X  αTGF  extracellular protein 1  
2X  EGFR  cell surface receptor 25 
3X  Dimeric EGFRTGF −α  cell surface complex 0   
4X  Phosphorylated active dimeric 
EGFRTGF −α cell surface complex 
0  
5X  Cytoplasmic inactive dimeric EGFRTGF −α  
complex 
0  
6X  Cytoplasmic EGFR  protein 0  
7X  Cytoplasmic αTGF  protein 1  
8X  EGFR RNA  1  
9X  αTGF RNA  0  
10X  γPLC  inactive , Ca-bound  1  
11X  γPLC  active, phosphorylated, Ca-bound 0  
12X  Nucleotide pool 5  
13X  Glucose cytoplasmic 1  
14X  Glucose extracellular 0  
 
 
Table 2. 
 
Coefficient Value Units Description 
1k  
3103 −×  11 −− snM  EGFRTGF −α  cell–surface complex 
formation rate 
1−k  
3108.3 −×  1−s  Rate of dissociation of EGFRTGF −α cell-
surface complex 
2k  
3101 −×  1−s  Rate of EGFRTGF −α  phosphorylation 
2−k  
6101 −×  1−s  Rate of EGFRTGF −α  dephosphorylation 
3k  
5105 −×  1−s  Rate of cell-surface EGFRTGF −α  
internalization 
4k  
5105 −×  1−s  Rate of phosphorylated EGFRTGF −α  
internalization 
5k  
2101 −×  1−s  Dissociation rate of cytoplasmic 
EGFRTGF −α  
5−k  
5104.1 −×  11 −− snM  Reverse dissociation rate of cytoplasmic 
EGFRTGF −α  
6k  
41067.1 −×  1−s  Rate of cytoplasmic EGFR  protein 
degradation 
7k  
41067.1 −×  1−s  Rate of cytoplasmic αTGF  protein 
degradation 
8k  
3105 −×  1−s  Rate of cytoplasmic EGFR insertion into the 
membrane  
8−k  
5105 −×  1−s  Rate of cell-surface EGFR  internalization 
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9k  1 
1−s  Rate of membrane insertion and secretion of αTGF  
10k  0.01 
1−s  Rate of down-regulation of EGFR expression 
by the EGFRTGF −α  complex 
11k  0.01 
1−s  Degradation of extracellular αTGF  
12k  083.0  
1−s  Rate of translation of RNAEGFR  
13k  0.036 
1−s  Basal transcription rate RNAEGFR  
14k  
3102.1 −×  1−s  RNAEGFR degradation rate 
15k  083.0  
1−s  Rate of translation of αTGF   
16k  02.0  
1−s  αTGF RNA degradation rate 
17k  0.2 
1−s  Basal transcription rate rnaTGF _α  
18k  1Mk , 1MV ,
1w  
Dimensionless 
constant [DC] 
Induction of αTGF transcription by activated 
EGFRTGF −α  at the cell surface 
1Mk  1 nM  Km of αTGF RNA transcriptional activation 
1MV  5 
11 −− snM  Rate of αTGF RNA transcriptional activation 
1w  1 DC Weight of Hills’ coefficient of αTGF RNA  
activation 
19k  0.1 
11 −− snM  Enhanced rate of γPLC activation by EGFR  
20k  0.1 
11 −− snM  Basal rate of activation of γPLC  
21k  0.05 
1−s  Rate of in-activation of γPLC  
22k  2Mk , 2MV ,
2w  
DC γPLC dependent rate of de-phosphorylation 
of phosphorylated EGFRTGF −α  
2Mk  5 nM  Km λPLC inhibition of phosphorylated 
surface EGFRTGF −α  
2MV  0.25 
11 −− snM  γPLC inhibition rate of EGFRTGF −α  
2w  1 DC Weight of Hill’s coefficient λPLC inhibition 
of phosphorylated surface EGFRTGF −α  
23k  
3101.0 −×  1−s  Lumped rate of glucose uptake 
24k  0.01 
11 −− snM  Increased rate of EGFRTGF −α  
phosphorylation by glucose 
gw  5 DC Weight of increase in rate of EGFRTGF −α  phosphorylation by glucose 
25k  
3105.3 −×  11 −− snM  Migratory signal 
26k  
3105.3 −×  11 −− snM  Mitotic signal I 
27k  0.0002 nM  Mitotic signal II 
28k  0.7 
1−s  Cytoplasmic glucose rate of degradation 
29k  1 nM  Constant total γPLC   
nr  0.7 stepmmol /  Glucose exhausting coefficient 
1D  
7107.6 −×  12 −scm  Diffusion coefficient of glucose  
2D  
71018.5 −×  12 −scm  Diffusion coefficient of αTGF  
oD  
5108 −×  12 −scm  Diffusion coefficient of oxygen tension 
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mT  18147 ±  mlpg /  Maximum concentration of αTGF  
aG  17 Lmmol /  Normal concentration of glucose 
mG  57 Lmmol /  Maximum concentration of glucose 
TS  0.3 molecules/min  Secretion rate of αTGF  
ak  0.0017 DC Normal concentration of oxygen 
mk  0.0025 DC Maximum concentration of oxygen 
 
 
Table 3.  
 
Symbol Variable Initial value [DC] 
15X  cdh1-APC complex 0.9 
16X  cyclin-CDK 0.01  
17X  Mass of the cell 5 
18X  Protein p27 0 
19X  RBNP 1  
 
 
Table 4.  
 
Coefficient Value Units 
30k  0.004 DC 
31k  0.05 DC 
32k  10 min
-1 
33k  35 min
-1 
34k  0.04 DC 
35k  0.04 DC 
36k  0.4 min
-1 
37k  1 min
-1 
38k  0.25 DC 
39k  0.04 min
-1 
40k  0.01 min
-1 
41k  10 DC 
42k  0.007 DC 
43k  0.01 DC 
44k  0.0017~0.0025 DC 
45k  0.01 DC 
46k  0.01 DC 
47k  0.1 DC 
 
